Paillas, Salomé <br/><br/>
Apoptosis and p53 are not involved in the anti-tumor efficacy of ¹²⁵I-labeled monoclonal antibodies targeting the cell membrane.  [electronic resource] 

 -  Nuclear medicine and biology  May 2013 
 - 471-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-9614 
<br/><br/><label>Standard No.: </label>10.1016/j.nucmedbio.2013.02.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--metabolism<br/>Antineoplastic Agents--metabolism<br/>Apoptosis--drug effects<br/>Bystander Effect--radiation effects<br/>Cell Membrane--drug effects<br/>Cytoplasm--drug effects<br/>ErbB Receptors--metabolism<br/>HCT116 Cells<br/>Humans<br/>Iodine Radioisotopes--therapeutic use<br/>Mitosis--drug effects<br/>Molecular Targeted Therapy<br/>Protein Transport--radiation effects<br/>Radioimmunotherapy<br/>Tumor Suppressor Protein p53--metabolism